Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.04
Delayed Data
As of May 28
 -0.02 / -0.97%
Today’s Change
1.53
Today|||52-Week Range
4.20
+10.87%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close2.06
Today’s open2.05
Day’s range2.02 - 2.14
Volume1,029,178
Average volume (3 months)313,702
Market cap$192.8M
Dividend yield--
Data as of 4:03pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-6.67%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.68%
P/E ratioNM
Price/Sales11.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc-0.03-0.50%
PSTIPluristem Therapeuti...0.000.00%
NDRMNeuroderm Ltd-0.01-0.08%
FATEFate Therapeutics In...+0.12+1.96%
Data as of 4:14pm ET, 05/28/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$15.2M
Annual profit (last year)-$29.9M
Net profit margin-197.51%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers